G1 THERAPEUTICS, INC.

Basic Information

79 TW Alexander Dr
RESEARCH TRIANGLE PARK, NC, 27709-0152

Company Profile

n/a

Additional Details

Field Value
DUNS: 828732813
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Development of GZ38-1, a Novel Protectant of Chemotherapy-Induced Myelosuppressio

    Amount: $984,830.00

    DESCRIPTION provided by applicant Myelosuppression continues to represent the major dose limiting toxicity of cancer chemotherapy resulting in considerable morbidity and mortality along with frequ ...

    SBIR Phase II 2014 Department of Health and Human Services National Institutes of Health
  2. Development of CDK4/6 Inhibitors as Novel Renal Protectants

    Amount: $159,836.00

    DESCRIPTION (provided by applicant): Acute kidney injury (AKI) is common, expensive, and highly morbid. There are currently no therapies for AKI, and prevention and treatment represents a 6.3 billion ...

    SBIR Phase I 2013 Department of Health and Human Services
  3. A new multiphase polymeric material for cushion-bearing orthopedic implants

    Amount: $151,115.00

    DESCRIPTION (provided by applicant): Myelosuppression continues to represent the major dose-limiting toxicity of cancer chemotherapy, resulting in considerable morbidity and mortality along with frequ ...

    SBIR Phase I 2013 Department of Health and Human Services
  4. Organismal Radioprotection Through Pharmacological Quiescence

    Amount: $3,000,000.00

    DESCRIPTION (provided by applicant): Syndrome (ARS), including a lethal myelosuppression due to the sensitivity of proliferating hematopoietic stem/progenitor cells (HSPCs) to ionizing radiation (IR). ...

    SBIR Phase II 2011 Department of Health and Human Services
  5. Organismal Radioprotection Through Pharmacological Quiescence

    Amount: $692,326.00

    DESCRIPTION (provided by applicant): Hematologic toxicity is a principal cause of morbidity and mortality after exposure to ionizing radiation (IR). G-Zero Therapeutics, with operations in the Res ...

    SBIR Phase I 2009 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government